Insiders BridgeBio Pharma, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 02:13:28 2024-05-21 pm EDT			5-day change	1st Jan Change
29.02 ^USD	-1.71%		-0.10%	-28.36%

May. 16	Transcript : BridgeBio Pharma, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM
May. 06	Certain Restricted Stock Unit Awards of BridgeBio Pharma, Inc. are subject to a Lock-Up Agreement Ending on 6-MAY-2024.	CI

Bridgebio Pharma Insider Sold Shares Worth $4,206,000, According to a Recent SEC Filing	Dec. 28	MT
Bridgebio Pharma Insider Sold Shares Worth $1,500,038, According to a Recent SEC Filing	Nov. 20	MT
Bridgebio Pharma Insider Sold Shares Worth $660,059, According to a Recent SEC Filing	Nov. 20	MT
Insider Sell: Bridgebio Pharma	23-08-18	MT
Insider Sell: Bridgebio Pharma	23-08-18	MT
Insider Sell: Bridgebio Pharma	23-05-18	MT
Insider Sell: Bridgebio Pharma	23-05-18	MT
Insider Sell: Bridgebio Pharma	23-05-05	MT
Insider Sell: Bridgebio Pharma	23-05-05	MT
Insider Sell: BridgeBio Pharma	23-03-06	MT
BridgeBio Pharma, Inc. Announces Board and Committee Changes	23-02-23	CI
Insider Sell: BridgeBio Pharma	23-02-07	MT
BridgeBio Pharma Executive to Join Atai Life Sciences as CFO	22-06-17	MT
Insider Buy: Bridgebio Pharma	22-01-04	MT
Bridgebio Pharma, Inc. Appoints Hannah Valantine to Its Board of Directors	21-10-25	CI
BridgeBio Pharma, Inc Announces Board Appointments	21-08-24	CI
Bridgebio Pharma, Inc. Appoints Finance and Pharmaceutical Leaders Fred Hassan, Andrea Ellis and Douglas Dachille to Its Board of Directors	21-08-18	CI
BridgeBio Pharma, Inc. Announces Executive Changes	21-01-04	CI
Bridgebio Pharma Announces the Resignation of Brian Stolz as Chief Operating Officer of the Company	20-10-23	CI
BridgeBio Pharma, Inc. Announces Board Appointments	20-06-24	CI

No results for this search